4.6 Article

Topical Application of Activity-based Probes for Visualization of Brain Tumor Tissue

Journal

PLOS ONE
Volume 7, Issue 3, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0033060

Keywords

-

Funding

  1. Wallace H. Coulter Translational Partners Grant Program Award
  2. Northeastern Ohio Animal Imaging Resource Center, an National Institutes of Health (NIH) of the Case Center for Imaging Research [R24CA110943]
  3. National Cancer Institute (NCI) [CA101954, CA116257]
  4. Ivy Brain Tumor Foundation
  5. Cancer Genome Atlas (TCGA)
  6. NIH [R01 EB005011-04]
  7. NIH Roadmap National Technology center for Networks and Pathways [U54020843-05]
  8. [ROI CA109620-01A1]

Ask authors/readers for more resources

Several investigators have shown the utility of systemically delivered optical imaging probes to image tumors in small animal models of cancer. Here we demonstrate an innovative method for imaging tumors and tumor margins during surgery. Specifically, we show that optical imaging probes topically applied to tumors and surrounding normal tissue rapidly differentiate between tissues. In contrast to systemic delivery of optical imaging probes which label tumors uniformly over time, topical probe application results in rapid and robust probe activation that is detectable as early as 5 minutes following application. Importantly, labeling is primarily associated with peri-tumor spaces. This methodology provides a means for rapid visualization of tumor and potentially infiltrating tumor cells and has potential applications for directed surgical excision of tumor tissues. Furthermore, this technology could find use in surgical resections for any tumors having differential regulation of cysteine cathepsin activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Behavioral Sciences

Toward the adoption of a Federal seizure action plan

Nathan T. Cohen

EPILEPSY & BEHAVIOR (2021)

Article Clinical Neurology

Spatiotemporal distribution and age of seizure onset in a pediatric epilepsy surgery cohort with cortical dysplasia

Natrujee Wiwattanadittakul, Sirorat Suwannachote, Xiaozhen You, Nathan T. Cohen, Tan Tran, Rochana Phuackchantuck, Tammy N. Tsuchida, Dewi F. Depositario-Cabacar, Tesfaye Zelleke, John M. Schreiber, Joan A. Conry, Amy Kao, Luca Bartolini, Chima Oluigbo, M. Isabel Almira-Suarez, Kathryn Havens, Matthew T. Whitehead, William Davis Gaillard

Summary: This study investigated the association of lesion volume and location with age of seizure onset in pediatric patients with CD undergoing epilepsy surgery. Larger CD lesions were associated with earlier onset epilepsy, with CD commonly occurring within the DMN and Limbic network. The percentage of CD overlapping the motor cortex correlated with earlier seizure onset.

EPILEPSY RESEARCH (2021)

Article Biochemistry & Molecular Biology

Selective activation of PFKL suppresses the phagocytic oxidative burst

Neri Amara, Madison P. Cooper, Maria A. Voronkova, Bradley A. Webb, Eric M. Lynch, Justin M. Kollman, Taylur Ma, Kebing Yu, Zijuan Lai, Dewakar Sangaraju, Nobuhiko Kayagaki, Kim Newton, Matthew Bogyo, Steven T. Staben, Vishva M. Dixit

Summary: The study demonstrates that small-molecule LDC7559 and its potent analog NA-11 inhibit the NOX2-dependent oxidative burst in neutrophils by activating PFKL, reducing inflammation and tissue damage. This provides a potential tool for selectively activating PFKL, the main isoform expressed in immune cells.
Review Biochemistry & Molecular Biology

Activity-Based Diagnostics: Recent Advances in the Development of Probes for Use with Diverse Detection Modalities

Ryan K. Muir, Matteo Guerra, Matthew M. Bogyo

Summary: This review highlights recent methodologies employed in activity-based diagnostics for detecting various diseases by leveraging the dysregulated enzyme expression and activity. These methods exhibit exquisite signal sensitivity and specificity in complex biological systems, and some have advanced into clinical trials.

ACS CHEMICAL BIOLOGY (2022)

Article Clinical Neurology

Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: A MELD study

Konrad Wagstyl, Kirstie Whitaker, Armin Raznahan, Jakob Seidlitz, Petra E. Vertes, Stephen Foldes, Zachary Humphreys, Wenhan Hu, Jiajie Mo, Marcus Likeman, Shirin Davies, Matteo Lenge, Nathan T. Cohen, Yingying Tang, Shan Wang, Mathilde Ripart, Aswin Chari, Martin Tisdall, Nuria Bargallo, Estefania Conde-Blanco, Jose Carlos Pariente, Saul Pascual-Diaz, Ignacio Delgado-Martinez, Carmen Perez-Enriquez, Ilaria Lagorio, Eugenio Abela, Nandini Mullatti, Jonathan O'Muircheartaigh, Katy Vecchiato, Yawu Liu, Maria Caligiuri, Ben Sinclair, Lucy Vivash, Anna Willard, Jothy Kandasamy, Ailsa McLellan, Drahoslav Sokol, Mira Semmelroch, Ane Kloster, Giske Opheim, Clarissa Yasuda, Kai Zhang, Khalid Hamandi, Carmen Barba, Renzo Guerrini, William Davis Gaillard, Xiaozhen You, Irene Wang, Sofia Gonzalez-Ortiz, Mariasavina Severino, Pasquale Striano, Domenico Tortora, Reetta Kalviainen, Antonio Gambardella, Angelo Labate, Patricia Desmond, Elaine Lui, Terry O'Brien, Jay Shetty, Graeme Jackson, John S. Duncan, Gavin P. Winston, Lars Pinborg, Fernando Cendes, Judith Helen Cross, Torsten Baldeweg, Sophie Adler

Summary: The study revealed that FCDs are unevenly distributed across the cerebral cortex and different lesion locations have significant impact on surgical outcomes. Lesions in the temporal and occipital lobes tend to be larger than frontal lobe lesions, leading to varying rates of seizure freedom post surgery.

EPILEPSIA (2022)

Editorial Material Chemistry, Physical

A 'Swiss army knife' probe for metastatic cancers

Matthew Bogyo

Summary: This nanosensor probe combines a tumour-targeting peptide, a diagnostic reporter, and an imaging contrast agent to enable early diagnosis, precision imaging, disease stratification, and downstream therapeutic response monitoring of metastatic cancer.

NATURE MATERIALS (2021)

Editorial Material Biochemical Research Methods

Uncovering an overlooked consequence of phosphorylation: change in cysteine reactivity

Markus Lakemeyer, Matthew Bogyo

NATURE METHODS (2022)

Article Clinical Neurology

Networks Underlie Temporal Onset of Dysplasia-Related Epilepsy: A MELD Study

Nathan T. Cohen, Xiaozhen You, Manu Krishnamurthy, Leigh N. Sepeta, Anqing Zhang, Chima Oluigbo, Matthew T. Whitehead, Taha Gholipour, Torsten Baldeweg, Konrad Wagstyl, Sophie Adler, William D. Gaillard

Summary: This study found that co-localization of FCD with distributed functional cortical networks is associated with age of epilepsy onset, with sensory neural networks (such as somatomotor and visual) linked to earlier onset and cognitive networks linked to later onset.

ANNALS OF NEUROLOGY (2022)

Article Clinical Neurology

Interpretable surface-based detection of focal cortical dysplasias: a Multi-centre Epilepsy Lesion Detection study

Hannah Spitzer, Mathilde Ripart, Kirstie Whitaker, Felice D'Arco, Kshitij Mankad, Andrew A. Chen, Antonio Napolitano, Luca De Palma, Alessandro De Benedictis, Stephen Foldes, Zachary Humphreys, Kai Zhang, Wenhan Hu, Jiajie Mo, Marcus Likeman, Shirin Davies, Christopher Guttler, Matteo Lenge, Nathan T. Cohen, Yingying Tang, Shan Wang, Aswin Chari, Martin Tisdall, Nuria Bargallo, Estefania Conde-Blanco, Jose Carlos Pariente, Saul Pascual-Diaz, Ignacio Delgado-Martinez, Carmen Perez-Enriquez, Ilaria Lagorio, Eugenio Abela, Nandini Mullatti, Jonathan O'Muircheartaigh, Katy Vecchiato, Yawu Liu, Maria Eugenia Caligiuri, Ben Sinclair, Lucy Vivash, Anna Willard, Jothy Kandasamy, Ailsa McLellan, Drahoslav Sokol, Mira Semmelroch, Ane G. Kloster, Giske Opheim, Leticia Ribeiro, Clarissa Yasuda, Camilla Rossi-Espagnet, Khalid Hamandi, Anna Tietze, Carmen Barba, Renzo Guerrini, William Davis Gaillard, Xiaozhen You, Irene Wang, Sofia Gonzalez-Ortiz, Mariasavina Severino, Pasquale Striano, Domenico Tortora, Reetta Kalviainen, Antonio Gambardella, Angelo Labate, Patricia Desmond, Elaine Lui, Terence O'Brien, Jay Shetty, Graeme Jackson, John S. Duncan, Gavin P. Winston, Lars H. Pinborg, Fernando Cendes, Fabian J. Theis, Russell T. Shinohara, J. Helen Cross, Torsten Baldeweg, Sophie Adler, Konrad Wagstyl

Summary: One of the challenges in applying machine learning to diagnostic biomedical imaging is the interpretability of algorithms. This study developed an open-source and interpretable machine-learning algorithm to automatically identify FCDs from structural MRI data, improving the confidence of physicians in identifying subtle MRI lesions in individuals with epilepsy.

BRAIN (2022)

Article Oncology

A Cathepsin-Targeted Quenched Activity-Based Probe Facilitates Enhanced Detection of Human Tumors during Resection

Gregory T. Kennedy, David E. Holt, Feredun S. Azari, Elizabeth Bernstein, Bilal Nadeem, Ashley Chang, Neil T. Sullivan, Alix Segil, Charuhas Desphande, Eric Bensen, John T. Santini Jr, John C. Kucharczuk, Edward J. Delikatny, Matthew Bogyo, A. J. Matthew Egan, Charles W. Bradley, Evgeniy Eruslanov, Jason D. Lickliter, Gavin Wright, Sunil Singhal

Summary: This study successfully translated a cathepsin activity-based probe (VGT-309) for fluorescence-guided surgery and conducted human research. The results showed that VGT-309 has good specificity and feasibility, and it can successfully label tumors during tumor resection.

CLINICAL CANCER RESEARCH (2022)

Article Oncology

Formulation of a Thermosensitive Imaging Hydrogel for Topical Application and Rapid Visualization of Tumor Margins in the Surgical Cavity

Ethan Walker, Daan G. J. Linders, Eric Abenojar, Xinning Wang, Hans Marten Hazelbag, Marieke E. Straver, Okker D. Bijlstra, Taryn L. March, Alexander L. Vahrmeijer, Agata Exner, Matthew Bogyo, James P. Basilion, Brian Straight

Summary: A formulation of a fluorescent molecular probe has been developed to enhance the resection quality for solid-tumor cancers. This formulation can be topically applied immediately after surgery and activates in the presence of residual cancer, providing a strong fluorescent signal to precisely delineate any remaining cancer cells. The utilization of this formulation has the potential to reduce re-excisions and improve patient quality of life.

CANCERS (2022)

Article Clinical Neurology

Prevalence and Risk Factors for Pharmacoresistance in Children With Focal Cortical Dysplasia-Related Epilepsy

Nathan T. Cohen, Phat Chang, Xiaozhen You, Anqing Zhang, Kathryn A. Havens, Chima O. Oluigbo, Matthew T. Whitehead, Taha Gholipour, William D. Gaillard

Summary: This study aimed to evaluate the prevalence and risk factors for pharmacoresistance in pediatric FCD-related epilepsy.

NEUROLOGY (2022)

Review Clinical Neurology

A scoping review of the functional magnetic resonance imaging-based functional connectivity of focal cortical dysplasia-related epilepsy

Nathan T. Cohen, Hua Xie, Taha Gholipour, William D. Gaillard

Summary: This article summarizes the evidence to date on the network basis of FCD-related epilepsy, and highlights the potential applications of rsfMRI in the diagnosis and treatment of FCD-related epilepsy. Numerous studies have shown a global disruption of cortical functional networks in FCD-related epilepsy, and the underlying pathological subtypes of FCD influence overall functional network patterns.

EPILEPSIA (2023)

Article Clinical Neurology

Limbic network co-localization predicts pharmacoresistance in dysplasia-related epilepsy

Nathan T. Cohen, Phat Chang, Taha Gholipour, Chima Oluigbo, L. Gilbert Vezina, Hua Xie, Anqing Zhang, William D. Gaillard

Summary: This study evaluated the role of focal cortical dysplasia co-localization to cortical functional networks in the development of pharmacoresistance. A total of 136 focal cortical dysplasia patients with 3.0 T or 1.5 T MRI were identified from clinical databases at Children's National Hospital. Clinical, radiological, and pathological factors were determined, and it was found that limbic network co-localization and focal to bilateral tonic-clonic seizures predicted pharmacoresistance. These findings provide important markers for clinicians to identify high-risk patients and facilitate earlier evaluation for epilepsy surgery.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)

Article Biochemistry & Molecular Biology

Identification of covalent inhibitors that disrupt M. tuberculosis growth by targeting multiple serine hydrolases involved in lipid metabolism

Brett M. Babin, Laura J. Keller, Yishay Pinto, Veronica L. Li, Andrew S. Eneim, Summer E. Vance, Stephanie M. Terrell, Ami S. Bhatt, Jonathan Z. Long, Matthew Bogyo

Summary: The increasing incidence of antibiotic-resistant Mycobacterium tuberculosis infections is a global health threat. In this study, researchers screened a narrow-spectrum inhibitor that successfully suppressed the growth of Mycobacterium tuberculosis. Analyses revealed that the inhibition of SH enzymes was linked to defects in cell envelope biogenesis. It was also found that resistance was primarily developed through the synthesis of mycocerates rather than mutations to SH targets.

CELL CHEMICAL BIOLOGY (2022)

No Data Available